Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 34 


 
Table of Contents   
ERRATUM  
Year : 2015  |  Volume : 21  |  Issue : 4  |  Page : 264
Doxorubicin-loaded drug-eluting beads versus conventional transarterial chemoembolization for nonresectable hepatocellular carcinoma: Erratum



Click here for correspondence address and email

Date of Web Publication29-Jul-2015
 

How to cite this article:
. Doxorubicin-loaded drug-eluting beads versus conventional transarterial chemoembolization for nonresectable hepatocellular carcinoma: Erratum. Saudi J Gastroenterol 2015;21:264

How to cite this URL:
. Doxorubicin-loaded drug-eluting beads versus conventional transarterial chemoembolization for nonresectable hepatocellular carcinoma: Erratum. Saudi J Gastroenterol [serial online] 2015 [cited 2019 Oct 15];21:264. Available from: http://www.saudijgastro.com/text.asp?2015/21/4/264/161648


In the article, “Doxorubicin-loaded Drug-eluting beads Versus Conventional Transarterial Chemoembolization for Nonresectable Hepatocellular Carcinoma”, which appeared in the pages 175-180, Issue 3, Vol. 21 of The Saudi Journal of Gastroenterology,[1] in the Abstract section, the percentages “17%” and “28%” in the sentence “Complete response (CR), objective response (OR), disease control (DC), and progressive disease (PD) rates were 11%, 24%, 17%, and 47%, respectively, in the DEB = TACE group compared with 4%, 32%, 28%, and 36%, respectively, in the c-TACE group.” should be written as “53%” and “64%” respectively.

In the Patients and Methods section, the word “non-HCC” in the first sentence “This study retrospectively compares the efficacy and safety profile of DEB-TACE with that of C-TACE in the management of non-HCC.” should be written as “nonresectable HCC”.

In the Patients and Methods section, the words “pre- and postclinical” in the third sentence “All patients had pre- and postclinical and laboratory evaluation as well as cross-sectional imaging with triphasic computed tomography (CT) or magnetic resonance (MR) of the liver prior to and following the procedure to assess for tumor response.” should be replaced with the word “clinical”.

These have now been corrected and reposted online.



 
   References Top

1.
Arabi M, BenMousa A, Bzeizi K, Garad F, Ahmed I, Al-Otaibi M. Doxorubicin-loaded drug-eluting beads versus conventional transarterial chemoembolization for nonresectable hepatocellular carcinoma. Saudi J Gastroenterol 2015;21:175-80.  Back to cited text no. 1
[PUBMED]  Medknow Journal  

Top
Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1319-3767.161648

Rights and Permissions




 

Top
  
 
  Search
 
  
  
    Similar in PUBMED
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed842    
    Printed12    
    Emailed0    
    PDF Downloaded147    
    Comments [Add]    

Recommend this journal